Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| IDEAYA Biosciences, Inc.(IDYA) | 1,500,000 | 1,700,000 | +200,000 | $65.82M | $59.69M | 6.88% | -$6.13M |
| argenx SEADR(ARGX) | 0 | 135,000 | +135,000 | $0 | $58.06M | 6.69% | +$58.06M |
| Merus N V | 0 | 850,000 | +850,000 | $0 | $50.29M | 5.80% | +$50.29M |
| Revolution Medicines, Inc.(RVMD) | 0 | 1,200,000 | +1,200,000 | $0 | $46.57M | 5.37% | +$46.57M |
| Structure Therapeutics IncADS | 720,058 | 1,100,000 | +379,942 | $30.86M | $43.20M | 4.98% | +$12.34M |
| Disc Medicine, Inc.(IRON) | 0 | 925,000 | +925,000 | $0 | $41.69M | 4.80% | +$41.69M |
| Ocular Therapeutix, Inc.(OCUL) | 5,811,436 | 5,150,000 | -661,436 | $51.99M | $35.23M | 4.06% | -$16.77M |
| Olema Pharmaceuticals, Inc.(OLMA) | 4,383,875 | 3,208,875 | -1,175,000 | $49.63M | $34.72M | 4.00% | -$14.91M |
| Vera Therapeutics, Inc.CL A(VERA) | 575,000 | 950,000 | +375,000 | $24.79M | $34.37M | 3.96% | +$9.58M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 0 | 750,000 | +750,000 | $0 | $32.98M | 3.80% | +$32.98M |
| Janux Therapeutics, Inc.(JANX) | 150,000 | 750,000 | +600,000 | $5.65M | $31.42M | 3.62% | +$25.77M |
| Xencor, Inc.(XNCR) | 650,000 | 1,500,000 | +850,000 | $14.38M | $28.39M | 3.27% | +$14.01M |
| Silence Therapeutics plcADS(SLN) | 1,476,061 | 1,476,061 | 0 | $31.09M | $28.05M | 3.23% | -$3.04M |
| Sarepta Therapeutics, Inc.(SRPT) | 400,000 | 150,000 | -250,000 | $51.78M | $23.70M | 2.73% | -$28.08M |
| Akero Therapeutics Inc | 800,000 | 800,000 | 0 | $20.21M | $18.77M | 2.16% | -$1.44M |
| Design Therapeutics, Inc.(DSGN) | 5,032,501 | 5,032,501 | 0 | $20.28M | $16.86M | 1.94% | -$3.42M |
| Annexon, Inc.(ANNX) | 3,050,000 | 3,300,000 | +250,000 | $21.87M | $16.17M | 1.86% | -$5.70M |
| Apellis Pharmaceuticals Inc COM | 800,000 | 400,000 | -400,000 | $47.02M | $15.34M | 1.77% | -$31.68M |
| Immunovant, Inc.(IMVT) | 1,775,000 | 575,000 | -1,200,000 | $57.35M | $15.18M | 1.75% | -$42.17M |
| Nuvalent Inc | 0 | 195,000 | +195,000 | $0 | $14.79M | 1.70% | +$14.79M |
| Xenon Pharmaceuticals Inc.(XENE) | 0 | 375,000 | +375,000 | $0 | $14.62M | 1.68% | +$14.62M |
| Ionis Pharmaceuticals, Inc.(IONS) | 0 | 300,000 | +300,000 | $0 | $14.30M | 1.65% | +$14.30M |
| Stoke Therapeutics, Inc.(STOK) | 0 | 1,050,000 | +1,050,000 | $0 | $14.19M | 1.63% | +$14.19M |
| Erasca, Inc.(ERAS) | 0 | 5,900,000 | +5,900,000 | $0 | $13.92M | 1.60% | +$13.92M |
| Enliven Therapeutics Inc | 1,574,220 | 595,000 | -979,220 | $26.41M | $13.91M | 1.60% | -$12.50M |
| Spyre Therapeutics, Inc.(SYRE) | 250,000 | 575,000 | +325,000 | $9.48M | $13.52M | 1.56% | +$4.04M |
| Engene Holdings Inc COM | 800,000 | 1,200,000 | +400,000 | $12.88M | $11.32M | 1.30% | -$1.57M |
| Cybin D/B/A Helus Pharma(HELP) | 40,000,000 | 40,000,000 | 0 | $16.54M | $10.84M | 1.25% | -$5.70M |
| Skye Bioscience, Inc.(SKYE) | 0 | 1,301,518 | +1,301,518 | $0 | $10.43M | 1.20% | +$10.43M |
| Elevation Oncology Inc | 1,000,000 | 3,850,000 | +2,850,000 | $5.13M | $10.39M | 1.20% | +$5.26M |
| Dyne Therapeutics, Inc.(DYN) | 1,730,000 | 265,000 | -1,465,000 | $49.11M | $9.35M | 1.08% | -$39.76M |
| Biohaven Ltd.(BHVN) | 0 | 250,000 | +250,000 | $0 | $8.68M | 1.00% | +$8.68M |
| Relay Therapeutics, Inc.(RLAY) | 0 | 1,300,000 | +1,300,000 | $0 | $8.48M | 0.98% | +$8.48M |
| Trevi Therapeutics, Inc.(TRVI) | 2,200,000 | 2,800,000 | +600,000 | $7.59M | $8.34M | 0.96% | +$754.0K |
| Rocket Pharmaceuticals, Inc.(RCKT) | 1,300,000 | 350,000 | -950,000 | $35.02M | $7.54M | 0.87% | -$27.49M |
| COMPASS Pathways plcADS(CMPS) | 257,980 | 1,159,030 | +901,050 | $1.81M | $7.00M | 0.81% | +$5.19M |
| Avalo Therapeutics, Inc.(AVTX) | 0 | 539,079 | +539,079 | $0 | $6.72M | 0.77% | +$6.72M |
| Lineage Cell Therapeutics, Inc.(LCTX) | 6,250,000 | 4,700,000 | -1,550,000 | $9.25M | $4.69M | 0.54% | -$4.56M |
| Atyr Pharma Inc | 3,100,000 | 3,000,000 | -100,000 | $6.04M | $4.68M | 0.54% | -$1.36M |
| Astria Therapeutics Inc | 1,244,960 | 500,000 | -744,960 | $17.52M | $4.55M | 0.52% | -$12.97M |
| Rapport Therapeutics, Inc.(RAPP) | 0 | 208,910 | +208,910 | $0 | $4.37M | 0.50% | +$4.37M |
| Nextcure Inc | 1,925,000 | 2,500,000 | +575,000 | $4.29M | $3.98M | 0.46% | -$317.8K |
| Neumora Therapeutics, Inc.(NMRA) | 382,345 | 300,000 | -82,345 | $6.19M | $2.95M | 0.34% | -$3.24M |
| Allakos Inc | 2,900,000 | 2,900,000 | 0 | $3.65M | $2.90M | 0.33% | -$754.0K |
| Adverum Biotechnologies Inc | 1,499,999 | 416,666 | -1,083,333 | $21.21M | $2.86M | 0.33% | -$18.35M |
| Applied Therapeutics Inc | 1,350,000 | 600,000 | -750,000 | $8.98M | $2.66M | 0.31% | -$6.31M |
| Cartesian Therapeutics, Inc.(RNAC) | 0 | 90,000 | +90,000 | $0 | $2.43M | 0.28% | +$2.43M |
| Unicycive Therapeutics Inc | 3,469,927 | 3,469,927 | 0 | $3.01M | $1.74M | 0.20% | -$1.27M |
| Io Biotech Inc | 493,827 | 493,827 | 0 | $854.3K | $577.8K | 0.07% | -$276.5K |
| Boundless Bio, Inc.(BOLD) | 200,000 | 117,806 | -82,194 | $2.85M | $433.1K | 0.05% | -$2.42M |
| Nuvation Bio Inc.W EXP 07 07 202(NUVB) | 66,666 | 66,666 | 0 | $22.7K | $10.7K | 0.00% | -$12.1K |
| Celldex Therapeutics, Inc.(CLDX) | 650,000 | 0 | -650,000 | $27.28M | $0 | — | -$27.28M |
| CG Oncology, Inc.(CGON) | 300,000 | 0 | -300,000 | $13.17M | $0 | — | -$13.17M |
| Cullinan Therapeutics, Inc.(CGEM) | 700,000 | 0 | -700,000 | $11.93M | $0 | — | -$11.93M |
| Cytokinetics, Incorporated(CYTK) | 100,000 | 0 | -100,000 | $7.01M | $0 | — | -$7.01M |
| Geron Corporation(GERN) | 9,000,000 | 0 | -9,000,000 | $29.70M | $0 | — | -$29.70M |
| Immatics N.V.SHS(IMTX) | 1,000,000 | 0 | -1,000,000 | $10.51M | $0 | — | -$10.51M |
| Immunic, Inc.(IMUX) | 421,184 | 0 | -421,184 | $556.0K | $0 | — | -$556.0K |
| Immunocore Holdings plcADS(IMCR) | 900,000 | 0 | -900,000 | $58.50M | $0 | — | -$58.50M |
| Kura Oncology, Inc.(KURA) | 300,000 | 0 | -300,000 | $6.40M | $0 | — | -$6.40M |
| Kyverna Therapeutics, Inc.(KYTX) | 500,000 | 0 | -500,000 | $12.42M | $0 | — | -$12.42M |
| Cypherpunk Technologies Inc.(CYPH) | 39,500 | 0 | -39,500 | $105.1K | $0 | — | -$105.1K |
| Praxis Precision Medicines, Inc.(PRAX) | 150,000 | 0 | -150,000 | $9.15M | $0 | — | -$9.15M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 350,000 | 0 | -350,000 | $8.33M | $0 | — | -$8.33M |
| Tourmaline Bio Inc | 99,208 | 0 | -99,208 | $2.27M | $0 | — | -$2.27M |
| Viridian Therapeutics, Inc.(VRDN) | 700,000 | 0 | -700,000 | $12.26M | $0 | — | -$12.26M |